This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Effect of Alcohol on ABCA1 Expression and Lipid Metabolism

This study has been terminated.
(It was found that 20g of alcohol daily had no effect on ABCA1 expression or HDL levels.)
Information provided by:
Bayside Health Identifier:
First received: November 14, 2007
Last updated: May 9, 2011
Last verified: May 2011
The purpose of this study is to investigate the effects of red wine on ABCA1 levels

Condition Intervention
Type 2 Diabetes Heart Disease Dietary Supplement: Red Wine

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Prevention

Further study details as provided by Bayside Health:

Primary Outcome Measures:
  • measurements of dyslipidemia [ Time Frame: 2 years ]

Secondary Outcome Measures:
  • lipid functionality [ Time Frame: 2 years ]

Estimated Enrollment: 20
Study Start Date: October 2007
Study Completion Date: December 2008
Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Intervention Details:
    Dietary Supplement: Red Wine
    20g alcohol daily/red wine for 4 weeks

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy participants
  • Aged 18-65 years
  • Free of overt coronary disease
  • BMI < 35
  • Fasting plasma glucose <6.1 mmol
  • Unmedicated
  • No major illness

Exclusion Criteria:

  • Unable to give informed consent
  • Smokers
  • Participants with alcoholism
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00558935

Australia, Victoria
Baker Heart Research Institute
Melbourne, Victoria, Australia, 3004
Sponsors and Collaborators
Bayside Health
Principal Investigator: Bronwyn A Kingwell, PhD Baker Heart Research Institute
  More Information Identifier: NCT00558935     History of Changes
Other Study ID Numbers: 24/06
Study First Received: November 14, 2007
Last Updated: May 9, 2011

Additional relevant MeSH terms:
Heart Diseases
Cardiovascular Diseases processed this record on September 21, 2017